Literature DB >> 14517393

On the regulation of fibroblast growth factor activity by heparin-like glycosaminoglycans.

R Sasisekharan1, S Ernst, G Venkataraman.   

Abstract

The activity of several angiogenic factors, like fibroblast growth factors (FGF), is modulated by heparin-like glycosaminoglycans (HLGAGs), which are acidic polysaccharides present in the extracellular matrix and at the cell surface. FGF binds to HLGAG in the matrix, where it is sequestered in a protected and inactive form, and at the cell surface, where it activates its cognate signaling receptor. Here we review recent progress in elucidating how HLGAG regulates FGF-induced signal transduction. Data from crystal structures of FGF complexed to active and inactive oligosaccharides is analyzed in the context of current models for HLGAG modulation of FGF activity. We propose that FGF can dimerize in several different modes, stabilized by HLGAGs. Individual dimer modes may represent active or inactive FGF and it is possible that different HLGAGs preferentially stabilize different FGF dimer modes. Understanding HLGAG-FGF interactions can provide leverage for new approaches to therapeutic control of angiogenesis.

Entities:  

Year:  1997        PMID: 14517393     DOI: 10.1023/A:1018318914258

Source DB:  PubMed          Journal:  Angiogenesis        ISSN: 0969-6970            Impact factor:   9.596


  23 in total

1.  Molecular characteristics of fibroblast growth factor-fibroblast growth factor receptor-heparin-like glycosaminoglycan complex.

Authors:  G Venkataraman; R Raman; V Sasisekharan; R Sasisekharan
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-30       Impact factor: 11.205

2.  Novel glycosaminoglycan biosynthetic inhibitors affect tumor-associated angiogenesis.

Authors:  Karthik Raman; Masayuki Ninomiya; Thao Kim Nu Nguyen; Yasuhiro Tsuzuki; Mamoru Koketsu; Balagurunathan Kuberan
Journal:  Biochem Biophys Res Commun       Date:  2010-11-19       Impact factor: 3.575

3.  Direct evidence for a predominantly exolytic processive mechanism for depolymerization of heparin-like glycosaminoglycans by heparinase I.

Authors:  S Ernst; A J Rhomberg; K Biemann; R Sasisekharan
Journal:  Proc Natl Acad Sci U S A       Date:  1998-04-14       Impact factor: 11.205

Review 4.  Role of heparan sulfate in ocular diseases.

Authors:  Paul J Park; Deepak Shukla
Journal:  Exp Eye Res       Date:  2013-02-11       Impact factor: 3.467

5.  Gekko-sulfated glycopeptide inhibits tumor angiogenesis by targeting basic fibroblast growth factor.

Authors:  Shuang-Xia Zhang; Cong Zhu; Yi Ba; Dan Chen; Xing-Long Zhou; Rui Cao; Li-Ping Wang; Yuan Ren; Xiong-Zhi Wu
Journal:  J Biol Chem       Date:  2012-02-25       Impact factor: 5.157

6.  Discovery of novel sulfonated small molecules that inhibit vascular tube formation.

Authors:  Karthik Raman; Rajesh Karuturi; Vimal P Swarup; Umesh R Desai; Balagurunathan Kuberan
Journal:  Bioorg Med Chem Lett       Date:  2012-04-16       Impact factor: 2.823

7.  The incorporation of bFGF mediated by heparin into PCL/gelatin composite fiber meshes for guided bone regeneration.

Authors:  Ji-hye Lee; Young Jun Lee; Hyeong-jin Cho; Dong Wan Kim; Heungsoo Shin
Journal:  Drug Deliv Transl Res       Date:  2015-04       Impact factor: 4.617

8.  Fibroblast growth factors 1 and 2 are distinct in oligomerization in the presence of heparin-like glycosaminoglycans.

Authors:  G Venkataraman; Z Shriver; J C Davis; R Sasisekharan
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-02       Impact factor: 11.205

9.  Heparin immobilized porous PLGA microspheres for angiogenic growth factor delivery.

Authors:  Hyun Jung Chung; Hong Kee Kim; Jun Jin Yoon; Tae Gwan Park
Journal:  Pharm Res       Date:  2006-08       Impact factor: 4.200

10.  Hepatocyte growth factor-mediated renal epithelial branching morphogenesis is regulated by glypican-4 expression.

Authors:  Anil Karihaloo; Sujata Kale; Norman D Rosenblum; Lloyd G Cantley
Journal:  Mol Cell Biol       Date:  2004-10       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.